12hon MSN
After decades of development and trials, Medtronic has secured U.S. Food and Drug Administration approval for adaptive ...
Medtronic said Monday the U.S. Food and Drug Administration has approved an adaptive brain-stimulation device as a treatment ...
Medtronic (MDT) announced FDA approval of BrainSense Adaptive deep brain stimulation – aDBS – and BrainSense Electrode Identifier. There is no cure for debilitating neurological conditions like ...
The U.S. Food and Drug Administration has approved Medtronic's deep brain stimulation system for use in patients with ...
T here is still no cure for Parkinson’s disease, but the U.S. Food and Drug Administration (FDA) approved a new deep brain ...
3h
Hosted on MSNFDA OKs adaptive brain pacemaker for Parkinson's treatmentThe Food and Drug Administration on Monday granted its first approval for a pacemaker-like device for the brain to ease ...
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real ...
Medtronic said the Food and Drug Administration approved a brain stimulation system for people afflicted with Parkinson's disease.
The FDA has approved adaptive deep brain stimulation (aDBS), a breakthrough therapy that adjusts in real time to Parkinson’s disease symptoms.
(NYSE: MDT) announced today that the FDA approved its BrainSense adaptive deep brain stimulation (aDBS) platform.
20h
GlobalData on MSNFDA approves Medtronic’s brain stimulation system for Parkinson’sThe FDA’s authorisation of Medtronic’s BrainSense follows the system’s receipt of a CE mark in Europe last month.
Shortly after obtaining a greenlight in Europe and after more than 10 years in development, Medtronic has now received the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results